INVITAE, A GENETIC TESTING COMPANY IN San Francisco, has begun a retest program involving 50,000 patients. Such a large retest effort is without precedent in the still-nascent genetic testing marketplace. Clinical laboratories and genetic testing companies commonly find that, in daily operations, a batch of samples produced unreliable or inaccurate results. These discoveries are made […]
- Regulatory Update
Estimating Total Costs When Genetic Tests Must Be Retested
- By Joseph Burns
- > From the Volume XXIV No. 12 - August 28, 2017 Issue
